Correction of glycogen storage disease type II (GSD II) by intramuscular administration of an adeno-associated virus (AAV) vector pseudotyped as AAV6
Publication
, Conference
Sun, BD; Chen, YT; Bird, A; Xu, F; Amalfitano, A; Koeberl, DD
Published in: MOLECULAR THERAPY
May 1, 2003
Duke Scholars
Published In
MOLECULAR THERAPY
ISSN
1525-0016
Publication Date
May 1, 2003
Volume
7
Issue
5
Start / End Page
S391 / S391
Location
WASHINGTON, D.C.
Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
Conference Name
6th Annual Meeting of the American-Society-of-Gene-Therapy
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Sun, B. D., Chen, Y. T., Bird, A., Xu, F., Amalfitano, A., & Koeberl, D. D. (2003). Correction of glycogen storage disease type II (GSD II) by intramuscular administration of an adeno-associated virus (AAV) vector pseudotyped as AAV6. In MOLECULAR THERAPY (Vol. 7, pp. S391–S391). WASHINGTON, D.C.: ACADEMIC PRESS INC ELSEVIER SCIENCE.
Sun, B. D., Y. T. Chen, A. Bird, F. Xu, A. Amalfitano, and D. D. Koeberl. “Correction of glycogen storage disease type II (GSD II) by intramuscular administration of an adeno-associated virus (AAV) vector pseudotyped as AAV6.” In MOLECULAR THERAPY, 7:S391–S391. ACADEMIC PRESS INC ELSEVIER SCIENCE, 2003.
Sun BD, Chen YT, Bird A, Xu F, Amalfitano A, Koeberl DD. Correction of glycogen storage disease type II (GSD II) by intramuscular administration of an adeno-associated virus (AAV) vector pseudotyped as AAV6. In: MOLECULAR THERAPY. ACADEMIC PRESS INC ELSEVIER SCIENCE; 2003. p. S391–S391.
Sun, B. D., et al. “Correction of glycogen storage disease type II (GSD II) by intramuscular administration of an adeno-associated virus (AAV) vector pseudotyped as AAV6.” MOLECULAR THERAPY, vol. 7, no. 5, ACADEMIC PRESS INC ELSEVIER SCIENCE, 2003, pp. S391–S391.
Sun BD, Chen YT, Bird A, Xu F, Amalfitano A, Koeberl DD. Correction of glycogen storage disease type II (GSD II) by intramuscular administration of an adeno-associated virus (AAV) vector pseudotyped as AAV6. MOLECULAR THERAPY. ACADEMIC PRESS INC ELSEVIER SCIENCE; 2003. p. S391–S391.
Published In
MOLECULAR THERAPY
ISSN
1525-0016
Publication Date
May 1, 2003
Volume
7
Issue
5
Start / End Page
S391 / S391
Location
WASHINGTON, D.C.
Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
Conference Name
6th Annual Meeting of the American-Society-of-Gene-Therapy
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences